Genentech
E7901
Genentech is a pioneering American biotechnology company known for developing groundbreaking therapies and being one of the first firms to apply genetic engineering to medicine.
All labels observed (3)
| Label | Occurrences |
|---|---|
| Genentech canonical | 32 |
| Genentech board of directors | 1 |
| Roche | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T92466 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Genentech Context triple: [Washington County, Oregon, hasMajorEmployer, Genentech]
-
A.
Biogen
Biogen is a major American biotechnology company known for developing therapies for neurological and neurodegenerative diseases.
-
B.
GlaxoSmithKline
GlaxoSmithKline is a global biopharmaceutical company known for developing and manufacturing prescription medicines, vaccines, and consumer healthcare products.
-
C.
Meredith Corporation
Meredith Corporation was a major American media and marketing company best known for its portfolio of lifestyle magazines and television broadcasting assets.
-
D.
Hewlett-Packard
Hewlett-Packard is a pioneering American technology company known for its innovations in computing, printers, and enterprise IT solutions.
-
E.
IBM
IBM is a multinational technology and consulting company known for its pioneering work in computer hardware, software, and enterprise services.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Genentech Target entity description: Genentech is a pioneering American biotechnology company known for developing groundbreaking therapies and being one of the first firms to apply genetic engineering to medicine.
-
A.
Biogen
Biogen is a major American biotechnology company known for developing therapies for neurological and neurodegenerative diseases.
-
B.
GlaxoSmithKline
GlaxoSmithKline is a global biopharmaceutical company known for developing and manufacturing prescription medicines, vaccines, and consumer healthcare products.
-
C.
Meredith Corporation
Meredith Corporation was a major American media and marketing company best known for its portfolio of lifestyle magazines and television broadcasting assets.
-
D.
Hewlett-Packard
Hewlett-Packard is a pioneering American technology company known for its innovations in computing, printers, and enterprise IT solutions.
-
E.
IBM
IBM is a multinational technology and consulting company known for its pioneering work in computer hardware, software, and enterprise services.
- F. None of above. chosen
Statements (49)
| Predicate | Object |
|---|---|
| instanceOf |
biotechnology company
ⓘ
pharmaceutical company ⓘ subsidiary ⓘ |
| acquiredBy | Roche ⓘ |
| acquisitionDate | 2009 ⓘ |
| appliesMethod | genetic engineering ⓘ |
| collaboratedWith | Eli Lilly and Company ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| develops |
biologic therapies
ⓘ
protein-based drugs ⓘ therapeutic antibodies ⓘ |
| focusesOn |
immunology
ⓘ
neuroscience ⓘ oncology ⓘ ophthalmology ⓘ |
| formerListedCompany | true ⓘ |
| foundedBy |
Herbert Boyer
ⓘ
Robert Swanson ⓘ |
| foundedIn | San Francisco Bay Area ⓘ |
| foundingDate | 1976 ⓘ |
| hasMajorTherapeuticArea |
autoimmune diseases
ⓘ
cancer ⓘ cardiovascular disease ⓘ |
| hasMotto | Doing now what patients need next ⓘ |
| hasResearchCenter | South San Francisco ⓘ |
| headquartersLocation |
South San Francisco
ⓘ
surface form:
South San Francisco, California
|
| industry |
biotechnology
ⓘ
pharmaceuticals ⓘ |
| knownFor |
monoclonal antibody therapies
ⓘ
recombinant DNA–based medicines ⓘ |
| legalForm | corporation ⓘ |
| locatedInTheAdministrativeTerritorialEntity |
California, United States
ⓘ
surface form:
California
|
| notableFor | being one of the first companies to commercialize recombinant human insulin ⓘ |
| notableProduct |
Activase
ⓘ
Avastin ⓘ Herceptin ⓘ Lucentis ⓘ Perjeta ⓘ Rituxan ⓘ Tecentriq ⓘ Xolair ⓘ |
| numberOfEmployees | over 10000 ⓘ |
| operatesIn | biopharmaceutical research and development ⓘ |
| parentOrganization | Roche ⓘ |
| partOf |
Roche
ⓘ
surface form:
Roche Group
|
| stockExchange | New York Stock Exchange ⓘ |
| subsidiaryOf | Roche ⓘ |
| tickerSymbol | DNA ⓘ |
| website | https://www.gene.com ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Genentech Description of subject: Genentech is a pioneering American biotechnology company known for developing groundbreaking therapies and being one of the first firms to apply genetic engineering to medicine.
Referenced by (34)
Full triples — surface form annotated when it differs from this entity's canonical label.
this entity surface form:
Roche
this entity surface form:
Genentech board of directors
subject surface form:
Herbert Boyer